vs
Golden Matrix Group, Inc.（GMGI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Golden Matrix Group, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.4倍（$49.6M vs $35.5M），Golden Matrix Group, Inc.净利率更高（-179.0% vs -304.2%，领先125.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -15.8%），Golden Matrix Group, Inc.自由现金流更多（$6.4M vs $-47.3M），过去两年Golden Matrix Group, Inc.的营收复合增速更高（104.6% vs 60.5%）
Golden Matrix Group Inc.是一家全球化游戏科技企业，开发并授权专属线上游戏平台、社交棋牌产品及互动游戏解决方案，服务覆盖北美、欧洲、亚太地区的B2B客户，同时运营面向普通用户的休闲游戏产品。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GMGI vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.6M | $35.5M |
| 净利润 | $-88.7M | $-108.1M |
| 毛利率 | 57.5% | 59.8% |
| 营业利润率 | -188.3% | -304.8% |
| 净利率 | -179.0% | -304.2% |
| 营收同比 | -15.8% | 681.7% |
| 净利润同比 | -4880.1% | 39.6% |
| 每股收益（稀释后） | $-7.73 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $49.6M | $35.5M | ||
| Q3 25 | $47.3M | $5.2M | ||
| Q2 25 | $43.2M | $19.2M | ||
| Q1 25 | $42.7M | $14.7M | ||
| Q4 24 | $58.9M | $4.5M | ||
| Q3 24 | $41.0M | $26.1M | ||
| Q2 24 | $39.4M | $14.4M | ||
| Q1 24 | $11.8M | $13.8M |
| Q4 25 | $-88.7M | $-108.1M | ||
| Q3 25 | $566.0K | $-162.3M | ||
| Q2 25 | $-3.6M | $-171.9M | ||
| Q1 25 | $-231.6K | $-202.5M | ||
| Q4 24 | $1.9M | $-178.9M | ||
| Q3 24 | $-3.4M | $-95.8M | ||
| Q2 24 | $64.9K | $-97.5M | ||
| Q1 24 | $74.5K | $-91.4M |
| Q4 25 | 57.5% | 59.8% | ||
| Q3 25 | 55.8% | -183.8% | ||
| Q2 25 | 56.4% | -4.9% | ||
| Q1 25 | 56.6% | -48.0% | ||
| Q4 24 | 69.8% | -181.4% | ||
| Q3 24 | 54.7% | 53.7% | ||
| Q2 24 | 55.0% | 36.2% | ||
| Q1 24 | 28.5% | 19.1% |
| Q4 25 | -188.3% | -304.8% | ||
| Q3 25 | -0.8% | -3327.6% | ||
| Q2 25 | -5.3% | -916.8% | ||
| Q1 25 | -0.2% | -1297.9% | ||
| Q4 24 | 5.6% | -4042.4% | ||
| Q3 24 | -2.4% | -377.1% | ||
| Q2 24 | 0.3% | -697.4% | ||
| Q1 24 | 2.4% | -698.4% |
| Q4 25 | -179.0% | -304.2% | ||
| Q3 25 | 1.2% | -3135.3% | ||
| Q2 25 | -8.3% | -894.2% | ||
| Q1 25 | -0.5% | -1373.3% | ||
| Q4 24 | 3.2% | -3935.5% | ||
| Q3 24 | -8.3% | -367.5% | ||
| Q2 24 | 0.2% | -676.6% | ||
| Q1 24 | 0.6% | -662.4% |
| Q4 25 | $-7.73 | $-0.17 | ||
| Q3 25 | $0.00 | $-0.36 | ||
| Q2 25 | $-0.03 | $-0.41 | ||
| Q1 25 | $0.00 | $-0.50 | ||
| Q4 24 | $-0.13 | $-0.56 | ||
| Q3 24 | $-0.03 | $-0.34 | ||
| Q2 24 | $0.00 | $-0.40 | ||
| Q1 24 | $0.00 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $46.5M | $1.1B |
| 总资产 | $118.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $46.5M | $1.1B | ||
| Q3 25 | $123.5M | $1.0B | ||
| Q2 25 | $121.3M | $919.1M | ||
| Q1 25 | $108.5M | $933.9M | ||
| Q4 24 | $105.1M | $1.0B | ||
| Q3 24 | $94.3M | $524.6M | ||
| Q2 24 | $90.4M | $584.4M | ||
| Q1 24 | $32.1M | $401.2M |
| Q4 25 | $118.1M | $1.5B | ||
| Q3 25 | $209.8M | $1.4B | ||
| Q2 25 | $210.3M | $1.3B | ||
| Q1 25 | $214.0M | $1.3B | ||
| Q4 24 | $213.7M | $1.4B | ||
| Q3 24 | $213.5M | $726.5M | ||
| Q2 24 | $191.5M | $775.9M | ||
| Q1 24 | $37.1M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $6.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 13.0% | -133.1% |
| 资本支出强度资本支出/营收 | 3.6% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $19.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $8.2M | $-46.1M | ||
| Q3 25 | $7.0M | $-117.4M | ||
| Q2 25 | $2.4M | $-76.4M | ||
| Q1 25 | $7.7M | $-132.0M | ||
| Q4 24 | — | $-115.4M | ||
| Q3 24 | $4.8M | $-59.2M | ||
| Q2 24 | — | $-82.2M | ||
| Q1 24 | $8.2K | $-102.3M |
| Q4 25 | $6.4M | $-47.3M | ||
| Q3 25 | $6.2M | $-117.6M | ||
| Q2 25 | $-89.4K | $-79.6M | ||
| Q1 25 | $6.6M | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | $2.3M | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | $6.7K | $-109.0M |
| Q4 25 | 13.0% | -133.1% | ||
| Q3 25 | 13.1% | -2272.5% | ||
| Q2 25 | -0.2% | -413.9% | ||
| Q1 25 | 15.5% | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | 5.6% | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | 0.1% | -789.9% |
| Q4 25 | 3.6% | 3.5% | ||
| Q3 25 | 1.8% | 4.7% | ||
| Q2 25 | 5.7% | 16.4% | ||
| Q1 25 | 2.6% | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | 6.0% | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | 12.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GMGI
| R Kings And CFAC | $43.8M | 88% |
| Other | $5.8M | 12% |
RXRX
暂无分部数据
